Similar articles

• Safe practices for compounding of parenteral nutrition.

  Cohen MR. Cohen MR. JPEN J Parenter Enteral Nutr. 2012 Mar;36(2 Suppl):14S-19S. doi: 10.1177/0148607111435332. JPEN J Parenter Enteral Nutr. 2012. PMID: 22383681
• Compounding vs standardized commercial parenteral nutrition product: pros and cons.

  Gervasio J. Gervasio J. JPEN J Parenter Enteral Nutr. 2012 Mar;36(2 Suppl):40S-41S. doi: 10.1177/0148607111435331. Epub 2012 Feb 2. JPEN J Parenter Enteral Nutr. 2012. PMID: 22301324
• Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.

  Kastango ES. Kastango ES. JPEN J Parenter Enteral Nutr. 2012 Mar;36(2 Suppl):38S-39S. doi: 10.1177/0148607111434779. Epub 2012 Jan 24. JPEN J Parenter Enteral Nutr. 2012. PMID: 22275322
• Overview of the parenteral nutrition use process.

  Boullata JI. Boullata JI. JPEN J Parenter Enteral Nutr. 2012 Mar;36(2 Suppl):10S-13S. doi: 10.1177/0148607111433624. Epub 2012 Jan 24. JPEN J Parenter Enteral Nutr. 2012. PMID: 22275321 Review.
• Drug Shortages: Effect on Parenteral Nutrition Therapy.

  Holcombe B, Mattox TW, Plogsted S. Holcombe B, et al. Nutr Clin Pract. 2018 Feb;33(1):53-61. doi: 10.1002/ncp.10052. Nutr Clin Pract. 2018. PMID: 29365360 Review.